FirsthandHealth
medRxiv PreprintsInternational20 November 2026

Circulating miRNA profiling identifies hsa-miR-23a-3p and a three-miRNA signature associated with serous ovarian cancer

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

High-grade serous ovarian carcinoma (HGSOC) is the most lethal subtype of epithelial ovarian cancer, highlighting the need for minimally invasive biomarkers that support disease detection and molecular characterization. Circulating microRNAs (miRNAs) have emerged as promising candidates, although their clinical applicability remains limited by methodological variability and insufficient validation. Plasma samples from 100 individuals (50 patients with ovarian cancer and 50 cancer-free controls) were initially collected from four biobanks. Following quality control, 94 samples (47 patients and
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.